ÌÇÐÄvlog´«Ã½

Neuroprosthetics Market Analysis

The Neuroprosthetics Market size is estimated at USD 12.01 billion in 2024, and is expected to reach USD 21 billion by 2029, growing at a CAGR of 11.83% during the forecast period (2024-2029).

The neuroprosthetics market was significantly impacted by the outbreak of the COVID-19 pandemic initially. According to an article published by PubMed Central in January 2021, hearing loss was said to be a relatively newly reported symptom of COVID-19, and the study further showed that two cochlear-implanted children showed symptoms of a sudden speech perception problem after being infected with COVID-19. Thus, owing to the aforementioned factors, the pandemic had a considerable impact on the studied market initially. However, currently, as the pandemic has subsided that market has gained traction and it is expected to have stable growth during the forecast period of the study.

Factors such as the increasing number of patients suffering from neurological disorders and nerve injury and the growing burden of hearing loss and related defects are expected to enhance the growth of the market.

People with hearing loss benefit from early identification as it enables the use of hearing aids, cochlear implants, and other devices. According to the World Health Organization, in 2021, approximately 2.5 billion population globally are estimated to experience hearing loss by 2050, and nearly 700 million are estimated to require hearing rehabilitation by 2050. Thus, the high burden of hearing loss among the global population is one of the major drivers for the growth of the neuroprosthetics market. The cochlear implant is one of the key neuroprosthetic devices that had provided immense benefits for people with deafness or severely hard-of-hearing. This device can also be used by patients who have experienced intense hearing loss caused by disease or injury, allowing them to hear sounds in their environment. Hence, with the increasing incidences of hearing loss, scientists are investing more in novel neuroprosthetics, which will drive the market over the forecast period.

According to the data by WHO in February 2022, epilepsy is a chronic noncommunicable neurological disease of the brain that affects people of all ages, and around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. It is estimated that nearly 80% of people with epilepsy live in low- and middle-income countries. The increasing prevalence of neurological diseases like epilepsy is also expected to enhance the market growth.

Furthermore, key developments in the market is also a major factor driving the growth of the market. For instance, in April 2021, Houston Methodist and Rice U. collaborated to develop translational neural prosthetics and interfaces to focus on restoring brain function after disease or injury. Thus, in view of the developments regarding neuroprosthetics, the neuroprosthetics market is expected to register healthy growth in the coming years.

Therefore, owing to the aforementioned factors such as the increasing number of patients suffering from neurological disorders and nerve injury, the growing burden of hearing loss and related defects, and the key developments in the market, the studied market is anticipated to witness growth over the analysis period. However, the availability of alternative treatment options and the high cost of neuroprosthetics are likely to impede the market's growth.

Neuroprosthetics Market Trends

This section covers the major market trends shaping the Neuroprosthetics Market according to our research experts:

The Input Neural Prosthetics Segment is Expected to Show a Significant Growth Over the Forecast Period

Neuroprosthetics Industry Segmentation

As per the scope of the report, neuroprosthetics is a branch of neuroscience and biomedical engineering concerned with developing neural prostheses. Neural prostheses are an array of devices that can substitute the functions of a motor, sensory, or cognitive modality that may have been damaged, as a result of an injury or a disease. The Neuroprosthetics Market is segmented by Type (Output Neural Prosthetics and Input Neural Prosthetics), Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, and Other Techniques), Application (Parkinson's Disease, Alzheimer's Disease, Epilepsy, Auditory Processing Disorders, Ophthalmic Disorders, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.